Tenaya Therapeutics, Inc.
TNYA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $265 | $99 | $63 | $124 |
| - Cash | $56 | $63 | $54 | $4 |
| + Debt | $12 | $12 | $13 | $14 |
| Enterprise Value | $220 | $49 | $22 | $133 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$2 | -$2 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$18 | -$21 | -$25 | -$23 |
| % Margin | – | – | – | – |
| Net Income | -$20 | -$23 | -$27 | -$24 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.12 | -0.14 | -0.24 | -0.28 |
| % Growth | 14.3% | 41.7% | 14.3% | – |
| Operating Cash Flow | -$16 | -$16 | -$23 | -$18 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$16 | -$16 | -$23 | -$19 |